Background: Emerging resistance of bacterial pathogens to clinically used drugs, including
not only first-choice but also second-and third-choice drugs, is alarming, but since the 1990s …

A series of synthetic antimicrobial peptidomimetics (SAMPs) have been prepared and found
to be highly active against several Gram-negative and Gram-positive bacterial strains. These …

An inexorable switch from antibiotics has become a major desideratum to overcome
antibiotic resistance. Bacteriocin from Lactobacillus casei, a cardinal probiotic was used to …

The widespread abuse of antibiotics has led to the use of antimicrobial peptides (AMPs) as a
replacement for the existing conventional therapeutic agents for combating microbial …

Antimicrobial resistance (AMR) is one of the greatest threats to human health that, by 2050,
will lead to more deaths from bacterial infections than cancer. New antimicrobial agents …

Covering: 1993 to the end of 2022As the rapid development of antibiotic resistance shrinks
the number of clinically available antibiotics, there is an urgent need for novel options to fill …

Synthetic antimicrobial peptides have recently emerged as promising candidates against
drug‐resistant pathogens. We identified a novel hexapeptide, Orn‐d‐Trp‐d‐Phe‐Ile‐d‐Phe …

Antimicrobial peptides (AMPs) attracted attention as potential source of novel antimicrobials.
Multi-drug resistant (MDR) infections have emerged as a global threat to public health in …

Abstract Drug-resistant microorganisms ('superbugs') present a serious challenge to the
success of antimicrobial treatments. Subsequently, there is a crucial need for novel bio …

Antimicrobial peptides (AMPs) are a group of polypeptide chains that have the property to
target and kill a myriad of microbial organisms including viruses, bacteria, protists, etc. The …